vs
Side-by-side financial comparison of CS Disco, Inc. (LAW) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $41.9M, roughly 1.4× CS Disco, Inc.). CS Disco, Inc. runs the higher net margin — -23.0% vs -246.8%, a 223.8% gap on every dollar of revenue. On growth, CS Disco, Inc. posted the faster year-over-year revenue change (14.3% vs 7.6%). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs 7.9%).
CS Disco, Inc. is a leading legal technology provider that develops cloud-based software solutions for legal practitioners. Its core offerings include e-discovery, document review, case management, and legal workflow automation tools, serving law firms, corporate legal teams, and government legal departments primarily in North America.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
LAW vs VNDA — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.9M | $57.2M |
| Net Profit | $-9.6M | $-141.2M |
| Gross Margin | 74.2% | — |
| Operating Margin | 1.7% | -70.5% |
| Net Margin | -23.0% | -246.8% |
| Revenue YoY | 14.3% | 7.6% |
| Net Profit YoY | 15.6% | -2774.3% |
| EPS (diluted) | $-0.15 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $41.9M | — | ||
| Q4 25 | $41.2M | $57.2M | ||
| Q3 25 | $40.9M | $56.3M | ||
| Q2 25 | $38.1M | $52.6M | ||
| Q1 25 | $36.7M | $50.0M | ||
| Q4 24 | $37.0M | $53.2M | ||
| Q3 24 | $36.3M | $47.7M | ||
| Q2 24 | $36.0M | $50.5M |
| Q1 26 | $-9.6M | — | ||
| Q4 25 | $-8.5M | $-141.2M | ||
| Q3 25 | $-13.7M | $-22.6M | ||
| Q2 25 | $-10.8M | $-27.2M | ||
| Q1 25 | $-11.4M | $-29.5M | ||
| Q4 24 | $-25.2M | $-4.9M | ||
| Q3 24 | $-9.2M | $-5.3M | ||
| Q2 24 | $-10.8M | $-4.5M |
| Q1 26 | 74.2% | — | ||
| Q4 25 | 75.1% | — | ||
| Q3 25 | 75.5% | — | ||
| Q2 25 | 74.6% | — | ||
| Q1 25 | 74.1% | — | ||
| Q4 24 | 74.2% | — | ||
| Q3 24 | 73.1% | — | ||
| Q2 24 | 74.2% | — |
| Q1 26 | 1.7% | — | ||
| Q4 25 | -22.4% | -70.5% | ||
| Q3 25 | -35.3% | -55.6% | ||
| Q2 25 | -31.0% | -73.2% | ||
| Q1 25 | -34.4% | -82.0% | ||
| Q4 24 | -70.6% | -19.3% | ||
| Q3 24 | -30.0% | -23.1% | ||
| Q2 24 | -34.4% | -20.1% |
| Q1 26 | -23.0% | — | ||
| Q4 25 | -20.7% | -246.8% | ||
| Q3 25 | -33.4% | -40.1% | ||
| Q2 25 | -28.4% | -51.7% | ||
| Q1 25 | -31.1% | -58.9% | ||
| Q4 24 | -68.1% | -9.2% | ||
| Q3 24 | -25.3% | -11.2% | ||
| Q2 24 | -30.1% | -9.0% |
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.13 | $-2.40 | ||
| Q3 25 | $-0.22 | $-0.38 | ||
| Q2 25 | $-0.18 | $-0.46 | ||
| Q1 25 | $-0.19 | $-0.50 | ||
| Q4 24 | $-0.43 | $-0.09 | ||
| Q3 24 | $-0.15 | $-0.09 | ||
| Q2 24 | $-0.18 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $103.0M | $84.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $123.9M | $327.2M |
| Total Assets | $162.4M | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $103.0M | — | ||
| Q4 25 | $114.6M | $84.9M | ||
| Q3 25 | $113.5M | $70.0M | ||
| Q2 25 | $114.5M | $81.0M | ||
| Q1 25 | $118.8M | $111.8M | ||
| Q4 24 | $129.1M | $102.3M | ||
| Q3 24 | $126.8M | $100.5M | ||
| Q2 24 | $130.0M | $103.0M |
| Q1 26 | $123.9M | — | ||
| Q4 25 | $128.1M | $327.2M | ||
| Q3 25 | $130.6M | $466.0M | ||
| Q2 25 | $137.9M | $486.3M | ||
| Q1 25 | $142.2M | $511.4M | ||
| Q4 24 | $147.5M | $538.5M | ||
| Q3 24 | $167.3M | $541.2M | ||
| Q2 24 | $170.9M | $542.5M |
| Q1 26 | $162.4M | — | ||
| Q4 25 | $173.6M | $488.9M | ||
| Q3 25 | $174.8M | $601.1M | ||
| Q2 25 | $164.9M | $624.7M | ||
| Q1 25 | $168.0M | $631.9M | ||
| Q4 24 | $180.3M | $656.2M | ||
| Q3 24 | $194.4M | $645.1M | ||
| Q2 24 | $198.0M | $651.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $-29.4M |
| Free Cash FlowOCF − Capex | — | $-29.5M |
| FCF MarginFCF / Revenue | — | -51.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-11.7M | — | ||
| Q4 25 | $762.0K | $-29.4M | ||
| Q3 25 | $-979.0K | $-31.6M | ||
| Q2 25 | $-4.2M | $-15.3M | ||
| Q1 25 | $-10.5M | $-33.1M | ||
| Q4 24 | $2.1M | $-1.8M | ||
| Q3 24 | $-2.9M | $-14.6M | ||
| Q2 24 | $-650.0K | $-6.9M |
| Q1 26 | — | — | ||
| Q4 25 | $255.0K | $-29.5M | ||
| Q3 25 | $-2.0M | $-31.8M | ||
| Q2 25 | $-5.2M | $-15.6M | ||
| Q1 25 | $-11.0M | $-33.6M | ||
| Q4 24 | $1.5M | $-2.0M | ||
| Q3 24 | $-3.7M | $-14.7M | ||
| Q2 24 | $-1.3M | $-7.0M |
| Q1 26 | — | — | ||
| Q4 25 | 0.6% | -51.6% | ||
| Q3 25 | -5.0% | -56.5% | ||
| Q2 25 | -13.6% | -29.6% | ||
| Q1 25 | -30.1% | -67.1% | ||
| Q4 24 | 4.1% | -3.8% | ||
| Q3 24 | -10.3% | -30.9% | ||
| Q2 24 | -3.6% | -13.9% |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 0.2% | ||
| Q3 25 | 2.6% | 0.3% | ||
| Q2 25 | 2.5% | 0.6% | ||
| Q1 25 | 1.4% | 0.9% | ||
| Q4 24 | 1.5% | 0.4% | ||
| Q3 24 | 2.4% | 0.3% | ||
| Q2 24 | 1.8% | 0.2% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LAW
Segment breakdown not available.
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
